Use the labels in the right column to find what you want. Or you can go thru them one by one, there are only 14615 posts. Searching is done in the search box in upper left corner. I blog on anything to do with stroke.DO NOT DO ANYTHING SUGGESTED HERE AS I AM NOT MEDICALLY TRAINED, YOUR DOCTOR IS, LISTEN TO THEM. BUT I BET THEY DON'T KNOW HOW TO GET YOU 100% RECOVERED. I DON'T EITHER, BUT HAVE PLENTY OF QUESTIONS FOR YOUR DOCTOR TO ANSWER.
Deans' stroke musings
Changing stroke rehab and research worldwide now.Time is Brain!Just think of all thetrillions and trillions of neuronsthateach daybecause there areeffective hyperacute therapies besides tPA(only 12% effective). I have 493 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.
What this blog is for:
Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It's quite disgusting that this information is not available from every stroke association and doctors group. My back ground story is here:http://oc1dean.blogspot.com/2010/11/my-background-story_8.html
Stroke is among the most common causes of
epilepsy after middle age. Patients with poststroke epilepsy (PSE)
differ in several
respects from patients with other forms of
structural–metabolic epilepsy; not least in age, age-related sensitivity
effects of antiepileptic drugs (AEDs), and specific
drug–drug interaction issues related to secondary-stroke prophylaxis.
Encouragingly, there has lately been remarkable
activity in the study of PSE. Three developments in PSE research deserve
focus. First, large prospective trials have
established the incidence and risk factors of PSE in the setting of
care. Stroke severity, cortical location, young
age, and haemorrhage remain the most important risk factors. Second,
more studies are needed, epidemiological data
indicate that the risk of PSE may be influenced, for instance, by statin
Third, studies are emerging regarding the treatment
and prognosis of PSE. Levetiracetam and lamotrigine may be well
treatment options and seizure freedom is achieved
in at least a similar proportion of patients as in other epilepsies.
new animal models such as photothrombotic stroke
gives hope of a more clear understanding of PSE epileptogenesis in the
future. In summary, PSE shows indications of
maturing into an independent epilepsy research field. This review
recent advances in our understanding of PSE and
provides an update on management issues such as diagnosis, AED
and prognosis. Finally, future research challenges
in the field are outlined.